ZYVERSA THERAPEUTICS, INC. Derivative Liability
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Derivative Liability of $0 as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:DerivativeLiabilities · last filed 2023-11-14
- 2023-09-30: Derivative Liability $0.00.
- 2023-06-30: Derivative Liability $0.00.
- 2023-03-31: Derivative Liability $0.00.
- 2022-12-31: Derivative Liability $0.00.
| Period end | Derivative Liability |
|---|---|
| 2023-09-30 | $0.00 10-Q · filed 2023-11-14 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-21 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-12 |
| 2022-12-31 | $0.00 10-Q · filed 2023-11-14 |
| 2021-12-31 | $76.59K 10-K · filed 2022-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |